文献速递瓣膜外科先天性心脏病外科

部分心脏移植用于二尖瓣置换的初步临床经验:实验性方法

Initial Clinical Experience With Partial Heart Transplantation for Mitral Valve Replacement: An Experimental Approach.
PubMed 文献 · Ann Thorac Surg · 2026-06-23

该研究报道了2例儿童二尖瓣部分心脏移植(PHT)的初步经验,两例均实现技术可行、即刻瓣膜功能良好和术后早期恢复。一例8个月时维持轻至中度反流,另一例2个月内出现进行性反流需再置换;组织病理显示移植物整合良好但存在乳头肌坏死,提示缺血损伤及后续腱索长度改变是反流可能机制。

要点

  • 儿童二尖瓣PHT技术上可行,但属实验性方法
  • 早期瓣膜功能良好,但进行性反流可导致再置换
  • 乳头肌缺血是重要局限,未来可尝试人工腱索

核心结论

  • 二尖瓣部分心脏移植技术上可行,但仍属实验性方法。
  • 早期经验显示植入成功且生物学整合良好,但乳头肌缺血是主要局限。

研究设计与样本

  • 两例儿科患者在不同机构经机构审查委员会批准接受二尖瓣部分心脏移植。
  • 两例均原位植入保留瓣下结构的供体二尖瓣。
  • 回顾手术细节、术后超声心动图及组织病理学分析以评估功能、移植物完整性和失败机制。

主要发现

  • 两例均显示技术可行、即刻瓣膜功能良好和术后早期恢复。
  • 一例在8个月时维持轻至中度反流。
  • 另一例在2个月内出现进行性反流,需再置换。
  • 组织病理学显示移植物整合良好、瓣叶和瓣环结构保留,但存在乳头肌坏死,符合缺血损伤及后续腱索长度改变是反流可能机制。

临床怎么用

  • 二尖瓣部分心脏移植可作为实验性选择,但需认识到乳头肌缺血和进行性反流风险。
  • 术后需密切超声随访监测反流进展,必要时准备再置换。

局限性

  • 仅2例初步经验,样本量小。
  • 随访时间短,长期结局未知。
  • 乳头肌缺血机制需进一步验证,未来需优化技术如人工腱索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mitral valve replacement in children is limited by the need for anticoagulation, lack of growth potential, and high reoperation rates. Partial heart transplantation (PHT) offers a living, growth-capable alternative. Although successfully applied to semilunar valves, its use in the atrioventricular position has not been described. This study reports the initial 2 cases of mitral PHT and evaluates early technical and physiologic outcomes. METHODS: Two pediatric patients underwent mitral PHT at separate institutions under institutional review board approval. In both cases, donor mitral valves with preserved subvalvular apparatus were implanted orthotopically. Procedural details, postoperative echocardiographic findings, and histopathologic analyses were reviewed to assess function, graft integrity, and mechanisms of failure. RESULTS: Both cases demonstrated technical feasibility, immediate valve competence, and early postoperative recovery. One patient maintained mild to moderate regurgitation at 8 months; the second patient had progressive regurgitation within 2 months, necessitating re-replacement. Histopathologic analysis revealed excellent graft integration and preserved leaflet and annular architecture but evidence of papillary muscle necrosis, consistent with ischemic injury and subsequent change in chordal length as the likely mechanism of regurgitation. CONCLUSIONS: Mitral PHT is technically feasible but remains an experimental approach. Early experience demonstrates successful implantation and biologic integration while identifying papillary muscle ischemia as a key limitation. Future refinements include the use of artificial chordae and careful selection of patients.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Overbey DM, Turek JW, Wolf SEM, et al. Initial Clinical Experience With Partial Heart Transplantation for Mitral Valve Replacement: An Experimental Approach. Ann Thorac Surg. 2026. PMID: 42336079. doi:10.1016/j.athoracsur.2026.06.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。